Sidebar 47: Patient Navigation..................................................................................................................................................................... 141 Sidebar 48: Patient Reported Outcomes.................................................................................................................................................. 142 Tables Table 1: Estimated Incidence and Mortality for Selected Cancers............................................................................................... 16 Table 2: Cancer-causing Pathogens..................................................................................................................................................... 48 Table 3: Newly FDA-approved Anticancer Agents: August 1, 2022-July 31, 2023................................................................. 77 Table 4: Summary of Current Clinical Trial Practices and Recommended Changes............................................................. 157 Supplemental Tables Table 1: Surgeries for the Prevention of Cancer............................................................................................................................... 191 Table 2: Newly FDA-approved Anticancer Agents: August 1, 2022-July 31, 2023 (Extended Table).............................................................................................................. 192 AACR Cancer Progress Report 2023 vi
RkJQdWJsaXNoZXIy NTkzMzk=